Greater beneficial effects of visceral fat reduction compared with subcutaneous fat reduction on parameters of the metabolic syndrome

被引:0
|
作者
Park, H
机构
来源
OBESITY RESEARCH | 2005年 / 13卷
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:A197 / A197
页数:1
相关论文
共 50 条
  • [21] Usefulness of differentiating metabolic syndrome into visceral fat type and subcutaneous fat type using ultrasonography in Japanese males
    Masahiro Sogabe
    Toshiya Okahisa
    Shingo Hibino
    Akira Yamanoi
    Journal of Gastroenterology, 2012, 47 : 293 - 299
  • [22] Usefulness of differentiating metabolic syndrome into visceral fat type and subcutaneous fat type using ultrasonography in Japanese males
    Sogabe, Masahiro
    Okahisa, Toshiya
    Hibino, Shingo
    Yamanoi, Akira
    JOURNAL OF GASTROENTEROLOGY, 2012, 47 (03) : 293 - 299
  • [23] COMBINED EFFECTS OF ADIPONECTIN AND VISCERAL FAT ON THE RISK OF METABOLIC SYNDROME
    Ha, K. H.
    Kim, D. J.
    Kim, H. C.
    ATHEROSCLEROSIS, 2016, 252 : E2 - E3
  • [24] Beneficial effects of subcutaneous fat transplantation on metabolism
    Tran, Thien T.
    Yamamoto, Yuji
    Gesta, Stephane
    Kahn, C. Ronald
    CELL METABOLISM, 2008, 7 (05) : 410 - 420
  • [25] METABOLIC SYNDROME RISK FACTORS DECREASE WITH LIFESTYLE INTERVENTION REDUCTION OF VISCERAL FAT IN OBESE POSTMENOPAUSAL WOMEN
    Joseph, L.
    Ryan, A.
    Blumenthal, J.
    Prigeon, R.
    Goldberg, A.
    GERONTOLOGIST, 2008, 48 : 499 - 499
  • [26] Greater visceral adiposity, not waist circumference or abdomen subcutaneous fat area, predicts a higher prevalence of metabolic syndrome in Japanese Americans
    Hayashi, T
    Boyko, EJ
    Mcneely, MJ
    Leonetti, DL
    Kahn, SE
    Fujimoto, WY
    DIABETES, 2005, 54 : A579 - A579
  • [27] Subcutaneous to visceral fat ratio: a possible risk factor for metabolic syndrome and cardiovascular diseases
    Shafqat, Muhammad Nabeel
    Haider, Miqdad
    DIABETES METABOLIC SYNDROME AND OBESITY-TARGETS AND THERAPY, 2018, 11 : 129 - 130
  • [28] Sibutramine and fat distribution: Is there a role for pharmacotherapy in abdominal/visceral fat reduction?
    Van Gaal, LF
    Wauters, MA
    Peiffer, FW
    De Leeuw, IH
    INTERNATIONAL JOURNAL OF OBESITY, 1998, 22 : S38 - S40
  • [29] Ultrasonography for the evaluation of visceral fat and the metabolic syndrome
    Meriño-Ibarra, E
    Artieda, M
    Cenarro, A
    Goicoechea, J
    Calvo, L
    Guallar, A
    Civeira, F
    METABOLISM-CLINICAL AND EXPERIMENTAL, 2005, 54 (09): : 1230 - 1235
  • [30] Liver fat, visceral fat and metabolic syndrome in patients with severe obesity
    Kawada, Tomoyuki
    INTERNATIONAL JOURNAL OF SURGERY, 2015, 22 : 153 - 153